131 related articles for article (PubMed ID: 11515734)
1. Severe hypercalcemia of an infant due to vitamin D toxicity associated with hypercholesterolemia.
Evliyaoğlu O; Berberoğlu M; Ocal G; Adiyaman P; Aycan Z
J Pediatr Endocrinol Metab; 2001; 14(7):915-9. PubMed ID: 11515734
[TBL] [Abstract][Full Text] [Related]
2. [Overdose or hypersensitivity to vitamin D?].
Hmami F; Oulmaati A; Amarti A; Kottler ML; Bouharrou A
Arch Pediatr; 2014 Oct; 21(10):1115-9. PubMed ID: 25129320
[TBL] [Abstract][Full Text] [Related]
3. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
Chatterjee M; Speiser PW
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1241-8. PubMed ID: 18183797
[TBL] [Abstract][Full Text] [Related]
5. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
[TBL] [Abstract][Full Text] [Related]
6. [Severe acute hypercalcemia in a child caused by accidental vitamin D poisoning].
Velin P; DuPont D
Pediatrie; 1988; 43(9):753-6. PubMed ID: 3068626
[TBL] [Abstract][Full Text] [Related]
7. High-molecular-weight hydroxypropylmethylcellulose. A cholesterol-lowering agent.
Dressman JB; Adair CH; Barnett JL; Berardi RR; Dunn-Kucharski VA; Jarvenpaa KM; Parr DD; Sowle CA; Swidan SZ; Tobey SW
Arch Intern Med; 1993 Jun; 153(11):1345-53. PubMed ID: 8507125
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
9. [Severe hypercalcemia due to vitamin D intoxication].
Chambellan-Tison C; Horen B; Plat-Wilson G; Moulin P; Claudet I
Arch Pediatr; 2007 Nov; 14(11):1328-32. PubMed ID: 17931839
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fish oil supplementation for treatment of moderate elevation of serum cholesterol.
Valdini AF; Glenn MA; Greenblatt L; Steinhardt S
J Fam Pract; 1990 Jan; 30(1):55-9. PubMed ID: 2403586
[TBL] [Abstract][Full Text] [Related]
13. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning.
Waele BD; Smitz J; Willems G
Pancreas; 1989; 4(3):378-80. PubMed ID: 2471970
[TBL] [Abstract][Full Text] [Related]
14. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
Keilani T; Schlueter WA; Levin ML; Batlle DC
Ann Intern Med; 1993 Feb; 118(4):246-54. PubMed ID: 8420442
[TBL] [Abstract][Full Text] [Related]
15. Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.
Rubins HB; Robins SJ
J Intern Med; 1992 Apr; 231(4):421-6. PubMed ID: 1588269
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia and acute renal insufficiency following use of a veterinary supplement.
Ronsoni MF; Santos HCD; Colombo BDS; Correa CG; Moritz APG; Coral MHC; Sande-Lee SV; Hohl A
J Bras Nefrol; 2017; 39(4):467-469. PubMed ID: 29319776
[TBL] [Abstract][Full Text] [Related]
17. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial.
Berthold HK; Sudhop T; von Bergmann K
JAMA; 1998 Jun; 279(23):1900-2. PubMed ID: 9634262
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].
Chotkowska E; Kurjata P; Kupść W
Pol Merkur Lekarski; 2001 Oct; 11(64):348-51. PubMed ID: 11770317
[TBL] [Abstract][Full Text] [Related]
19. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
Liacouras CA; Coates PM; Gallagher PR; Cortner JA
J Pediatr; 1993 Mar; 122(3):477-82. PubMed ID: 8441109
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
